WallStreetZenWallStreetZen

NASDAQ: BNTC
Benitec Biopharma Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BNTC past revenue growth

How has BNTC's revenue growth performed historically?
Company
-9.33%
Industry
69.53%
Market
14.01%
BNTC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BNTC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

BNTC earnings and revenue history

Current Revenue
$68.0k
Current Earnings
-$20.0M
Current Profit Margin
-29,364.7%

BNTC Return on Equity

Current Company
-256%
Current Industry
-18%
Current Market
30.8%
BNTC's Return on Equity (-256%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BNTC announces earnings.

BNTC Return on Assets

Current Company
-180.7%
Current Industry
0.9%
BNTC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BNTC Return on Capital Employed

Current Company
-393.39%
Current Industry
14.1%

BNTC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BNTC$68.00k-$19.57M-$19.97M+75.81%N/A
SILO$72.10k-$4.21M-$4.21M+91.44%N/A
AYTU$104.12M-$23.35M-$32.30M+96.31%N/A
CANF$810.00k-$10.11M-$10.17M+0.53%N/A
WINT$0.00-$35.95M-$35.19M-100.00%N/A
View Top Biotech Stocks

Benitec Biopharma Earnings & Revenue FAQ

What were BNTC's earnings last quarter?

On Invalid Date, Benitec Biopharma (NASDAQ: BNTC) reported Q1 2023 earnings per share (EPS) of -$0.00, up 50% year over year. Total Benitec Biopharma earnings for the quarter were -$4.40 million. In the same quarter last year, Benitec Biopharma's earnings per share (EPS) was -$0.00.

If you're new to stock investing, here's how to buy Benitec Biopharma stock.

What was BNTC's earnings growth in the past year?

As of Q2 2023, Benitec Biopharma's earnings has grown year over year. Benitec Biopharma's earnings in the past year totalled -$19.97 million.

What was BNTC's revenue last quarter?

On Invalid Date, Benitec Biopharma (NASDAQ: BNTC) reported Q1 2023 revenue of $54.00 thousand up 12.5% year over year. In the same quarter last year, Benitec Biopharma's revenue was $48.00 thousand.

What was BNTC's revenue growth in the past year?

As of Q2 2023, Benitec Biopharma's revenue has grown -9.33% year over year. This is 78.87 percentage points lower than the US Biotechnology industry revenue growth rate of 69.53%. Benitec Biopharma's revenue in the past year totalled $68.00 thousand.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.